T1000	Negation 983 990	absence
E1000	Negation:T1000 Scope:T1001
T1001	Span 983 1041	absence of HGF but defective motility (e.g., USP3, ATXN3L)
T1002	Speculation 430 433	may
E1001	Speculation:T1002 Scope:T1003
T1003	Span 430 508	may target proteins for degradation or coordinate signal transduction pathways
T1004	Speculation 1157 1164	suggest
E1002	Speculation:T1004 Scope:T1005
T1005	Span 1157 1342	suggest widespread involvement of the ubiquitin system at multiple stages of the Met activation response, implying significant crosstalk with phosphorylation-based transduction pathways
T1006	Negation 1061 1064	not
E1003	Negation:T1006 Scope:T1007
T1007	Span 1061 1146	not incur defective receptor, phosphatidylinositol 3-kinase, or MAP kinase activation
T1008	Speculation 1404 1407	may
E1004	Speculation:T1008 Scope:T1009
T1009	Span 1404 1458	may offer a therapeutic approach to contain metastasis
T1010	Speculation 1263 1271	implying
E1005	Speculation:T1010 Scope:T1011
T1011	Span 1263 1342	implying significant crosstalk with phosphorylation-based transduction pathways
